Cofactor-enabled functional expression of fruit fly, honeybee, and bumblebee nicotinic receptors reveals picomolar neonicotinoid actions

Autor: Ihara, Makoto, Furutani, Shogo, Shigetou, Sho, Shimada, Shota, Niki, Kunihiro, Komori, Yuma, Kamiya, Masaki, Koizumi, Wataru, Magara, Leo, Hikida, Mai, Noguchi, Akira, Okuhara, Daiki, Yoshinari, Yuto, Kondo, Shu, Tanimoto, Hiromu, Niwa, Ryusuke, Sattelle, David B., Matsuda, Kazuhiko

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America, 2020 Jul . 117(28), 16283-16291.

Externí odkaz: https://www.jstor.org/stable/26935219

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Loops D, E and G in the Drosophila Dα1 subunit contribute to high neonicotinoid sensitivity of Dα1-chicken β2 nicotinic acetylcholine receptor.

Autor: Ihara, Makoto, Hikida, Mai, Matsushita, Hiroyuki, Yamanaka, Kyosuke, Kishimoto, Yuya, Kubo, Kazuki, Watanabe, Shun, Sakamoto, Mifumi, Matsui, Koutaro, Yamaguchi, Akihiro, Okuhara, Daiki, Furutani, Shogo, Sattelle, David B, Matsuda, Kazuhiko

Publikováno v: British Journal of Pharmacology; Jun2018, Vol. 175 Issue 11, p1999-2012, 14p, 4 Diagrams, 2 Charts, 3 Graphs

A two-dose viral-vectored Plasmodium vivax multistage vaccine confers durable protection and transmission-blockade in a pre-clinical study.

Autor: Yamamoto Y; Laboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, Kanazawa, Ishikawa, Japan., Fabbri C; Instituto Leônidas & Maria Deane/Fiocruz Amazônia, Laboratório de Diagnóstico e Controle e Doenças Infecciosas da Amazônia, Manaus, Amazonas, Brazil.; Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Unidade de Pesquisa Clínica Carlos Borborema - UPCCB, Manaus, Amazonas, Brazil., Okuhara D; Laboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, Kanazawa, Ishikawa, Japan., Takagi R; Laboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, Kanazawa, Ishikawa, Japan., Kawabata Y; Laboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, Kanazawa, Ishikawa, Japan., Katayama T; Laboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, Kanazawa, Ishikawa, Japan., Iyori M; Department of Pharmaceutical Sciences, Musashino University, Tokyo, Japan., Hasyim AA; Laboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, Kanazawa, Ishikawa, Japan., Sakamoto A; Laboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, Kanazawa, Ishikawa, Japan., Mizukami H; Division of Genetic Therapeutics, Jichi Medical University, Shimono, Tochigi, Japan., Shida H; Laboratory of Primate Model, Research Center for Infectious Diseases, Institute for Frontier Life and Medical Science, Kyoto University, Kyoto, Japan., Lopes S; Instituto Leônidas & Maria Deane/Fiocruz Amazônia, Laboratório de Diagnóstico e Controle e Doenças Infecciosas da Amazônia, Manaus, Amazonas, Brazil.; Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Unidade de Pesquisa Clínica Carlos Borborema - UPCCB, Manaus, Amazonas, Brazil., Yoshida S; Laboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, Kanazawa, Ishikawa, Japan.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Apr 30; Vol. 15, pp. 1372584. Date of Electronic Publication: 2024 Apr 30 (Print Publication: 2024).